Using a most cost-effective drug to treat some of the most common and dangerous heart conditions could save the NHS a considerable amount of money ...

Switching from beta-blockers to digoxin as first line therapy for older patients with AF could produce £100m in NHS savings annually.

First used in 1785, this century-old medication is now emerging as a modern solution with significant healthcare benefits ...

Children will no longer be prescribed puberty blockers at gender identity clinics, NHS England has confirmed. The Government said it welcomed the “landmark decision”, adding it would help ...

The following is a summary of “Cost-effectiveness of digoxin versus beta blockers in permanent atrial fibrillation: the Rate Control Therapy Evaluation in Permanent Atrial Fibrillation (RATE-AF) ...

Beta-blockers work by blocking the actions of hormones in your body that stimulate your heart. This allows your heart to beat with less speed and force, leading to a decrease in blood pressure.

A 240-year-old drug called digoxin could save the National Health Service (NHS) at least £100 million each year when treating older patients with atrial fibrillation and heart failure. This was ...

An “unethical” NHS puberty blocker trial has been threatened with legal action by campaigners. Lawyers acting for Keira Bell, a former patient of the Tavistock Clinic, which was shut down amid ...

“With puberty blockers outside the NHS now banned and a waiting list in excess of five years, families and young people have been left with no safe, accessible or affordable options. “The ...

Last year following a review of gender services in the UK, a recommendation was made to stop the prescription of puberty blockers. NHS England was first to announce that children under 18 would no ...

Last year following a review of gender services in the UK, a recommendation was made to stop the prescription of puberty blockers. NHS England was first to announce that children under 18 would no ...